Annemieke Wouterse
Senior Investment Manager @ NV NOM
Groningen, The Netherlands
Annemieke Wouterse is a Senior Investment Manager at N.V. NOM, Investment and Development Company for the Northern Netherlands. Before joining NOM in 1999, Annemieke held various senior consultancy and controller roles in companies like Bakkenist, AVEBE and AkzoNobel. Annemieke is a Member of the Supervisory Board at Mucosis since September2010. Annemieke has a financial background and is involved with several highly innovative companies in the region. Annemieke holds a Bachelor's degree in Economics from Erasmus University Rotterdam as well as a Master's degree in Finance and Controller from Vrije Universiteit Amsterdam. Annemieke completed the supervisory board program at the Nyenrode Business University.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Annemieke Wouterse invests in
Stages Annemieke Wouterse invests in
Countries Annemieke Wouterse invests in
Investment Focus
Industry
- Health Diagnostics 2 (67%)
- Health Care 1 (33%)
- Therapeutics 1 (33%)
- Manufacturing 1 (33%)
- Medical Device 1 (33%)
Stage
- Seed 1 (33%)
- Pre-Seed 1 (33%)
- Funding Round 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Reyedar
|
Reyedar is a manufacturer of a medical tool intended to hasten the early detection of visual impairment and neurodegenerative disorders. They offer stress-free, non-invasive functional vision examinations to opticians, optometrists, ophthalmologists, and researchers. | $3.3M / Jul 05, 2023 | |
|
Reyedar
|
Reyedar is a manufacturer of a medical tool intended to hasten the early detection of visual impairment and neurodegenerative disorders. They offer stress-free, non-invasive functional vision examinations to opticians, optometrists, ophthalmologists, and researchers. | $3.3M / Seed / Jul 05, 2023 | |
Protyon
|
Protyon provides an analysis service examines the effect of mutations in specific proteins targeted for treatment in lung cancer. | $654.7K / Pre-Seed / May 11, 2023 |
Co-Investors
About NV NOM
NOM is investing in the development of the Northern Netherlands. And you, the entrepreneur, good use. You can rely on us in all phases of your business. From the start until your organization is as good as grown. And even further to succession or acquisition.
NV NOM Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Annemieke Wouterse
Senior Investment Manager
|
|||
Ytsen van der Meer
Investment manager
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Annemieke Wouterse invest in?
Annemieke Wouterse invests primarily in Health Diagnostics, Health Care and Therapeutics startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Annemieke Wouterse last invest?
The most recent investment recorded for Annemieke Wouterse closed in Jul 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
